Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below. Just click on the icons to get to the download page.
Or continue login with
The pharmaceutical company saw revenue rise 6.6 percent yoy to Rp 12.37 trillion in the January-June...
PT Kalbe Farma, a leading Indonesian pharmaceutical group, has reported net sales of Rp 6.015 trilli...
PT Kalbe Genexine Biologics (KGBio) focuses on producing cancer immunotherapy drugs, a rising altern...
Indonesia's national consortium for COVID-19 vaccine development has set a target to finish...
Publicly listed pharmaceutical company Kalbe Farma has signed an agreement with South Korea-based bi...
PT Kalbe Farma is bracing for the impact of COVID-19 on its business in the second quarter and hopin...
The country’s 50 richest still managed to add US$5.6 billion to their combined wealth, which t...
Despite being deemed a resilient sector by market players because people always buy consumer goods r...
The growth of household spending, which accounts for more than half of the country’s gross dom...
As of Thursday, the sector had lost 8.22 percent of its value and become the fourth-worst performer ...